Kolon TissueGene, Inc.
Biotechnology company · Rockville, Maryland, United States
Kolon TissueGene, Inc. is a biotechnology company headquartered in Rockville, Maryland, United States. It has reported private securities offerings to the US SEC, most recently $35 million sold in a notice filed in 2024.
Profile compiled from public records. Is this your company? Request a correction or update
Kolon TissueGene at a glance
Typebiotechnology company
HeadquartersRockville, Maryland, United States
SEC CIK1326507
What does Kolon TissueGene do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $35 million sold (2024).
Frequently asked questions about Kolon TissueGene
Where is Kolon TissueGene headquartered?
Kolon TissueGene, Inc. is headquartered in Rockville, Maryland, United States.
What does Kolon TissueGene do?
Kolon TissueGene, Inc. is a biotechnology company.
Similar companies
- REGENXBIO Inc.Rockville, Maryland, United States
- Immunomic Therapeutics, Inc.Rockville, Maryland, United States
- OncoC4, Inc.Rockville, Maryland, United States
- Integrated Biotherapeutics LLCRockville, Maryland, United States
- Sanaria Inc.Rockville, Maryland, United States
- CASI Pharmaceuticals, Inc (DE)Rockville, Maryland, United States
- OncoImmune, Inc.Rockville, Maryland, United States
- Rise Therapeutics, LLCRockville, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences